Labels

Monday, September 30, 2013

ICEBREAKERS

There must have been some initial large investment of money for these 2 doctors who I call “icebreakers” because they’ve started much earlier than the complete medical environment to treat using a TNF-alpha medication (Etanercept or Enbrel) to tre
at victims like me to have neurological improvements following either a stroke or TBI (= brain damage).
Normally whenever someone starts doing something new with success there’s a number of “followers” filing right behind the innovators or icebreakers, but this is the case that makes the complete exception, I can’t believe that it’s just a matter of the money needed for the initial investment, that can be made again by treating the first few patients, given that the basic ingredient is pretty inexpensive and not much of it, is really needed.
The sad result of this exception is that I’m going to have to wait for the “potential” future approval of the use of Enbrel for TBI by the FDA that only someone else – other than Amgen/Pfizer – will fund for the medical testing (trial) and approval.
These two “icebreakers” are geniuses for having been able to see and forecast the payoff of their investment or maybe they really took very seriously their Hippocratic Oath of dedication to the improvement of their patients’ conditions.
Again it’s very possible that my complete ignorance of the “guess-science” is making me see this case in a very twisted way, but I still I cannot figure out a reason why none of my doctors hasn’t at least accepted my begging to at least “try” it, especially given that all they keep doing all day long with all of their patients is to “try” to prescribe something that nobody ever knows if it’ll work for them/their conditions.

As I’ve been writing here for months I’m left only with the wish/hope that at next year’s worldwide neurological convention there will be agreement among all these scientists of guessing that using Enbrel can truly help the neurological recovery of an injured brain. Only 5 more months…..




No comments: